These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14585237)

  • 1. Treatment of Ascites.
    Choudhury J; Sanyal AJ
    Curr Treat Options Gastroenterol; 2003 Dec; 6(6):481-491. PubMed ID: 14585237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites.
    Garcia N; Sanyal AJ
    Curr Treat Options Gastroenterol; 2001 Dec; 4(6):527-537. PubMed ID: 11696279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of refractory ascites.
    Singhal S; Baikati KK; Jabbour II; Anand S
    Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of ascites in cirrhosis.
    Wong F
    J Gastroenterol Hepatol; 2012 Jan; 27(1):11-20. PubMed ID: 21916992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and therapy of ascites in liver cirrhosis.
    Biecker E
    World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
    Praharaj DL; Anand AC
    J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites and Chronic Liver Disease in Children.
    Bolia R; Srivastava A
    Indian J Pediatr; 2024 Mar; 91(3):270-279. PubMed ID: 37310583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cirrhotic ascites: Seven-step treatment protocol based on the Japanese evidence-based clinical practice guidelines for liver cirrhosis 2020.
    Yoshiji H
    Hepatol Res; 2023 Jun; ():. PubMed ID: 37332123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
    Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transjugular intrahepatic portosystemic shunt for the treatment of refractory ascites].
    Kanazawa H; Osada Y; Yoshimoto H; Narahara Y; Mamiya Y; Saitoh H; Matusaka S; Tada N; Kobayashi M; Kawamata H; Kumazaki T
    Nihon Shokakibyo Gakkai Zasshi; 1998 Mar; 95(3):221-9. PubMed ID: 9558878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and management of pediatric ascites.
    Sabri M; Saps M; Peters JM
    Curr Gastroenterol Rep; 2003 Jun; 5(3):240-6. PubMed ID: 12734047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.